Cover Image
市場調查報告書

生物科技/醫藥品服務外包市場分析:各類服務(諮詢,審核·審查,法務,產品維持管理,產品設計·開發及其他),及市場區隔預測

Biotechnology/Pharmaceutical Services Outsourcing Market Analysis, By Service (Consulting, Auditing & Assessment, Regulatory Affairs, Product Maintenance, Product Design & Development, and Others), And Segment Forecasts, 2014 - 2025

出版商 Grand View Research, Inc. 商品編碼 421186
出版日期 內容資訊 英文 137 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
生物科技/醫藥品服務外包市場分析:各類服務(諮詢,審核·審查,法務,產品維持管理,產品設計·開發及其他),及市場區隔預測 Biotechnology/Pharmaceutical Services Outsourcing Market Analysis, By Service (Consulting, Auditing & Assessment, Regulatory Affairs, Product Maintenance, Product Design & Development, and Others), And Segment Forecasts, 2014 - 2025
出版日期: 2016年12月14日 內容資訊: 英文 137 Pages
簡介

本報告提供全球生物科技/醫藥品服務外包市場相關調查,彙整市場趨勢,各類服務,各地區趨勢,及打入市場的主要企業簡介等資料。

第1章 調查方法與範圍

第2章 摘要整理

第3章 市場變動,趨勢,範圍

  • 市場區隔和範圍
  • 市場規模與成長預測
  • 促進要素分析
  • 阻礙要素分析
  • 優先的主要機會
  • 產業分析:波特五力分析
  • 大環境分析
  • 服務價格分析

第4章 各類服務預測·趨勢分析

  • 各類服務趨勢分析
  • 諮詢服務
    • 法律規章
    • Remediation
    • 品管
    • 其他
  • 審核·審查
  • 法務服務
    • 法務服務市場
    • 臨床實驗申請·產品登記
    • 法務文件作成·發行
    • 法律上的代表
    • 其他
  • 產品維持管理服務
  • 產品產品·開發
  • 產品實驗·驗證
  • 教育訓練
  • 其他

第5章 各地區預測·趨勢分析

  • 各地區市場佔有率
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東·非洲

第6章 競爭環境

  • 策略架構
  • 企業簡介
目錄
Product Code: GVR-1-68038-326-3

The global biotechnology services outsourcing market is expected to reach USD 92.9 billion by 2025, according to a new report by Grand View Research, Inc. Pharmaceutical industry has been adaptive of the function of outsourcing certain clinical and corporate functions as early as 2002. Among the services outsourced, clinical trial management and contract manufacturing were the forerunners. For instance, Johnson & Johnson was the first pharmaceutical company to outsource its applications development and maintenance (ADM).

In 2015, over USD 50.0 billion was spent on pharmaceutical R&D activities majorly on oncology, diabetes, and autoimmune therapy classes, which is expected to propel the biotechnology services outsourcing market growth over the forecast period.

Shrinking profit margins coupled with rising competition in the market space, and augmenting regulatory burden are other vital impact rendering factors. The pharmaceutical services outsourcing market is expected to register growth at a CAGR of 8.7% during the forecast period. On the other hand, pending immigration legislations in the U.S. may hinder business economics and outsourcing risks.

Pharmaceutical and biotechnology industries in Europe are significantly investing in R&D in the recent year owing to rising demand for advanced medicines. This may be attributed to increasing aging population, incidence of chronic diseases, and communicable diseases.

Further key findings from the study suggest:

Consulting services are inclusive of regulatory compliance, remediation, and quality management systems consulting, which is expected to dominate the pharmaceutical services outsourcing market in 2025.

In 2013, the U.S. FDA revised the guidelines for registration trials of drugs used in the treatment of acute bacterial skin and skin structure infections, thereby promoting growth of regulatory affairs services.

Other services such as contract manufacturing, product upgrade, and IT consulting services are projected to grow swiftly. Increasing focus on generic medicine and regional expansions in developing regions are some of the key contributing factors.

Presence of cheap labor, skilled personnel and rapid growth of the pharmaceutical industry within the Asia Pacific region presents numerous opportunities for service providers, thereby representing a lucrative growth rate over the forecast period.

Service based expertise may be found in players such QuintilesIMS, Parexel Corporation, Lachman Consultant Services, Inc., Concept Heidelberg GmbH, and others. These players compete on the basis of service quality, competitive pricing, and long-term relations with healthcare industry participants.

Table of Contents

Chapter 1 Research Methodology

  • 1.1 Information Procurement
  • 1.2 Data Analysis
  • 1.3 Country wise market calculation

Chapter 2 Executive Summary

  • 2.1 Market Snapshot

Chapter 3 Pharmaceutical/Biotechnology Services Outsourcing Market Variables, Trends, & Scope

  • 3.1 Market Segmentation & Scope
  • 3.2 Market size and growth prospects
  • 3.3 Market driver analysis
  • 3.4 Market restraint analysis
  • 3.5 Key Opportunities Prioritized
  • 3.6 Industry Analysis Porter's
  • 3.7 Pharmaceutical/biotechnology services outsourcing PESTEL Analysis
  • 3.8 Service pricing analysis

Chapter 4 Pharmaceutical/Biotechnology Services Outsourcing Market: Service Estimates & Trend Analysis

  • 4.1 Pharmaceutical/biotechnology services outsourcing market: Service movement analysis
  • 4.2 Consulting services
    • 4.2.1 Consulting services market, 2014 - 2025 (USD Million)
    • 4.2.2 Regulatory compliance
      • 4.2.2.1 Regulatory compliance based consulting services market, 2014 - 2025 (USD Million)
    • 4.2.3 Remediation
      • 4.2.3.1 Remediation based consulting services market, 2014 - 2025 (USD Million)
    • 4.2.4 Quality management
      • 4.2.4.1 Quality management based consulting services market, 2014 - 2025 (USD Million)
    • 4.2.5 Other
      • 4.2.5.1 Other consulting services market, 2014 - 2025 (USD Million)
  • 4.3 Auditing & assessment
    • 4.3.1 Auditing & assessment services market, 2014 - 2025 (USD Million)
  • 4.4 Regulatory affairs services
    • 4.4.1 Regulatory affairs services market, 2014 - 2025 (USD Million)
    • 4.4.2 Clinical trial applications & product registration
      • 4.4.2.1 Clinical trial application & product registration based regulatory affairs services market, 2014 - 2025 (USD Million)
    • 4.4.3 Regulatory writing & publishing
      • 4.4.3.1 Regulatory writing & publishing based regulatory affairs services market, 2014 - 2025 (USD Million)
    • 4.4.4 Legal representation
      • 4.4.4.1 Legal representation based regulatory affairs services market, 2014 - 2025 (USD Million)
    • 4.4.5 Other
      • 4.4.5.1 Other regulatory affairs services market, 2014 - 2025 (USD Million)
  • 4.5 Product maintenance services
    • 4.5.1 Product maintenance services market, 2014 - 2025 (USD Million)
  • 4.6 Product design & development
    • 4.6.1 Product design & development services market, 2014 - 2025 (USD Million)
  • 4.7 Product testing & validation
    • 4.7.1 Product testing & validation services market, 2014 - 2025 (USD Million)
  • 4.8 Training & education
    • 4.8.1 Training & education services market, 2014 - 2025 (USD Million)
  • 4.9 Other services
    • 4.9.1 Other services market, 2014 - 2025 (USD Million)

Chapter 5 Pharmaceutical/Biotechnology Services Outsourcing Market: Regional Estimates & Trend Analysis

  • 5.1 Pharmaceutical/biotechnology services outsourcing Market Share by Region, 2015 & 2025
  • 5.2 North America
    • 5.2.1 North America pharmaceutical/biotechnology services outsourcing market estimates and forecasts, 2014 - 2025
    • 5.2.2 U.S.
      • 5.2.2.1 U.S. pharmaceutical/biotechnology services outsourcing market estimates and forecasts, 2014 - 2025
    • 5.2.3 Canada
      • 5.2.3.1 Canada pharmaceutical/biotechnology services outsourcing market estimates and forecasts, 2014 - 2025
  • 5.3 Europe
    • 5.3.1 Europe pharmaceutical/biotechnology services outsourcing market estimates and forecasts, 2014 - 2025
    • 5.3.2 UK
      • 5.3.2.1 UK pharmaceutical/biotechnology services outsourcing market estimates and forecasts, 2014 - 2025
    • 5.3.3 Germany
      • 5.3.3.1 Germany pharmaceutical/biotechnology services outsourcing market estimates and forecasts, 2014 - 2025
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific pharmaceutical/biotechnology services outsourcing market estimates and forecasts, 2014 - 2025
    • 5.4.2 Japan
      • 5.4.2.1 Japan pharmaceutical/biotechnology services outsourcing market estimates and forecasts, 2014 - 2025
    • 5.4.3 China
      • 5.4.3.1 China pharmaceutical/biotechnology services outsourcing market estimates and forecasts, 2014 - 2025
  • 5.5 Latin America
    • 5.5.1 Latin America pharmaceutical/biotechnology services outsourcing market estimates and forecasts, 2014 - 2025
    • 5.5.2 Brazil
      • 5.5.2.1 Brazil pharmaceutical/biotechnology services outsourcing market estimates and forecasts, 2014 - 2025
    • 5.5.3 Mexico
      • 5.5.3.1 Mexico pharmaceutical/biotechnology services outsourcing market estimates and forecasts, 2014 - 2025
  • 5.6 MEA
    • 5.6.1 MEA pharmaceutical/biotechnology services outsourcing market estimates and forecasts, 2014 - 2025
    • 5.6.2 South Africa
      • 5.6.2.1 South Africa pharmaceutical/biotechnology services outsourcing market estimates and forecasts, 2014 - 2025

Chapter 6 Competitive Landscape

  • 6.1 Strategy framework
  • 6.2 Company Profiles
    • 6.2.1 The Quantic Group
      • 6.2.1.1 Company Overview
      • 6.2.1.2 Financial performance
      • 6.2.1.3 Geographic foothold
      • 6.2.1.4 Product Benchmarking
    • 6.2.2 QuintilesIMS
      • 6.2.2.1 Company Overview
      • 6.2.2.2 Financial Performance
      • 6.2.2.3 Geographic foothold
      • 6.2.2.4 Product Benchmarking
      • 6.2.2.5 Strategic Initiatives
    • 6.2.3 Parexel International Corporation
      • 6.2.3.1 Company Overview
      • 6.2.3.2 Financial Performance
      • 6.2.3.3 Geographic foothold
      • 6.2.3.4 Service Benchmarking
      • 6.2.3.5 Strategic Initiatives
    • 6.2.4 Lachman Consultant Services, Inc.
      • 6.2.4.1 Company Overview
      • 6.2.4.2 Financial performance
      • 6.2.4.3 Geographic foothold
      • 6.2.4.4 Product Benchmarking
      • 6.2.4.5 Strategic Initiatives
    • 6.2.5 GMP Pharmaceuticals Pty Ltd.
      • 6.2.5.1 Company Overview
      • 6.2.5.2 Geographic foothold
      • 6.2.5.3 Geographic foothold
      • 6.2.5.4 Product Benchmarking
      • 6.2.5.5 Strategic Initiatives
    • 6.2.6 Management Forum
      • 6.2.6.1 Company overview
      • 6.2.6.2 Financial performance
      • 6.2.6.3 Geographic foothold
      • 6.2.6.4 Product benchmarking
      • 6.2.6.5 Strategic initiatives
    • 6.2.7 Quality Context Ltd.
      • 6.2.7.1 Company overview
      • 6.2.7.2 Geographic foothold
      • 6.2.7.3 Product benchmarking
      • 6.2.7.4 Strategic initiatives
    • 6.2.8 Inspired Pharma Training Ltd.
      • 6.2.8.1 Company overview
      • 6.2.8.2 Financial performance
      • 6.2.8.3 Geographic foothold
      • 6.2.8.4 Product benchmarking
    • 6.2.9 Concept Heidelberg GmbH
      • 6.2.9.1 Company overview
      • 6.2.9.2 Financial performance
      • 6.2.9.3 Geographic foothold
      • 6.2.9.4 Product benchmarking
      • 6.2.9.5 Strategic initiatives
    • 6.2.10 Reading Scientific Services Ltd. (RSSL)
      • 6.2.10.1 Company overview
      • 6.2.10.2 Financial performance
      • 6.2.10.3 Geographic foothold
      • 6.2.10.4 Product benchmarking
      • 6.2.10.5 Strategic initiatives

List of Tables

  • TABLE 1 Country wise market share percentage
  • TABLE 2 Pricing strategy for outsourcing business models
  • TABLE 3 Outsourcing services average prices, 2015
  • TABLE 4 Partnerships between CRO's and pharmaceutical firms
  • TABLE 5 Provisional rate for consulting roles
  • TABLE 6 North America pharmaceutical/biotechnology services outsourcing market, by region, 2014 - 2025 (USD Million)
  • TABLE 7 North America pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
  • TABLE 8 North America pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
  • TABLE 9 North America pharma/biotechnology regulatory affairs services market, by service, 2014 - 2025 (USD Million)
  • TABLE 10 U.S. pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
  • TABLE 11 U.S. pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
  • TABLE 12 U.S. pharma/biotechnology regulatory affairs services market, by service, 2014 - 2025 (USD Million)
  • TABLE 13 Canada pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
  • TABLE 14 Canada pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
  • TABLE 15 Canada pharma/biotechnology regulatory affairs services market, by service, 2014 - 2025 (USD Million)
  • TABLE 16 Europe pharmaceutical/biotechnology services outsourcing market, by region, 2014 - 2025 (USD Million)
  • TABLE 17 Europe pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
  • TABLE 18 Europe pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
  • TABLE 19 Europe pharma/biotechnology regulatory affairs services market, by service, 2014 - 2025 (USD Million)
  • TABLE 20 UK pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
  • TABLE 21 UK pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
  • TABLE 22 UK pharma/biotechnology regulatory affairs services market, by service, 2014 - 2025 (USD Million)
  • TABLE 23 Germany pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
  • TABLE 24 Germany pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
  • TABLE 25 Germany pharma/biotechnology regulatory affairs services market, by service, 2014 - 2025 (USD Million)
  • TABLE 26 Asia Pacific pharmaceutical/biotechnology services outsourcing market, by region, 2014 - 2025 (USD Million)
  • TABLE 27 Asia Pacific pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
  • TABLE 28 Asia Pacific pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
  • TABLE 29 Asia Pacific pharma/biotechnology regulatory affairs services market, by service, 2014 - 2025 (USD Million)
  • TABLE 30 Japan pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
  • TABLE 31 Japan pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
  • TABLE 32 Japan pharma/biotechnology regulatory affairs services market, by service, 2014 - 2025 (USD Million)
  • TABLE 33 China pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
  • TABLE 34 China pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
  • TABLE 35 China pharma/biotechnology regulatory affairs services market, by service, 2014 - 2025 (USD Million)
  • TABLE 36 Latin America pharmaceutical/biotechnology services outsourcing market, by region, 2014 - 2025 (USD Million)
  • TABLE 37 Latin America pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
  • TABLE 38 Latin America pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
  • TABLE 39 Latin America pharma/biotechnology regulatory affairs services market, by service, 2014 - 2025 (USD Million)
  • TABLE 40 Brazil pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
  • TABLE 41 Brazil pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
  • TABLE 42 Brazil pharma/biotechnology regulatory affairs services market, by service, 2014 - 2025 (USD Million)
  • TABLE 43 Mexico pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
  • TABLE 44 Mexico pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
  • TABLE 45 Mexico pharma/biotechnology regulatory affairs services market, by service, 2014 - 2025 (USD Million)
  • TABLE 46 MEA pharmaceutical/biotechnology services outsourcing market, by region, 2014 - 2025 (USD Million)
  • TABLE 47 MEA pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
  • TABLE 48 MEA pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
  • TABLE 49 MEA pharma/biotechnology regulatory affairs services market, by service, 2014 - 2025 (USD Million)
  • TABLE 50 South Africa pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
  • TABLE 51 South Africa pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
  • TABLE 52 South Africa pharma/biotechnology regulatory affairs services market, by service, 2014 - 2025 (USD Million)
  • TABLE 53 Regional office locations

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information procurement
  • FIG. 3 Primary research pattern
  • FIG. 4 Market research approaches
  • FIG. 5 Value chain based sizing & forecasting
  • FIG. 6 QFD modeling for market share assessment
  • FIG. 7 Primary interviews in North America
  • FIG. 8 Primary interviews in Europe
  • FIG. 9 Primary interviews in Asia Pacific
  • FIG. 10 Primary interviews in Latin America
  • FIG. 11 Primary interviews In MEA
  • FIG. 12 Market summary, 2015 (USD Million)
  • FIG. 13 Market trends & outlook
  • FIG. 14 Pharmaceutical/biotechnology services outsourcing market: Market segmentation
  • FIG. 15 Pharmaceutical/biotechnology services outsourcing market revenue, (USD Million), 2014 - 2025
  • FIG. 16 Market driver relevance analysis (Current & future impact)
  • FIG. 17 Increasing number of the FDA approved NME, 2008-2014
  • FIG. 18 Number of mergers and acquisition vs value (USD Billion), 2010-2014
  • FIG. 19 Average cost per new drug development, 2000 - 2011 (USD Million)
  • FIG. 20 Failure rates in phase transitions during biopharmaceutical development
  • FIG. 21 Market restraint relevance analysis (Current & future impact)
  • FIG. 22 Key Opportunities Prioritized
  • FIG. 23 Pharmaceutical/biotechnology services outsourcing: Porter's analysis
  • FIG. 24 Pharmaceutical/biotechnology services outsourcing PESTEL analysis
  • FIG. 25 Reasons for outsourcing, 2015
  • FIG. 26 Heat map for pricing models opted by competitors
  • FIG. 27 Pharmaceutical/biotechnology services outsourcing market service outlook key takeaways
  • FIG. 28 Pharmaceutical/biotechnology services outsourcing market: Service movement analysis
  • FIG. 29 Consulting services market, 2014 - 2025 (USD Million)
  • FIG. 30 Regulatory compliance based consulting services market, 2014 - 2025 (USD Million)
  • FIG. 31 Remediation based consulting services market, 2014 - 2025 (USD Million)
  • FIG. 32 Quality management based consulting services market, 2014 - 2025 (USD Million)
  • FIG. 33 Other consulting services market, 2014 - 2025 (USD Million)
  • FIG. 34 Auditing & assessment services market, 2014 - 2025 (USD Million)
  • FIG. 35 Regulatory affairs services market, 2014 - 2025 (USD Million)
  • FIG. 36 Clinical trial application & product registration based regulatory affairs services market, 2014 - 2025 (USD Million)
  • FIG. 37 Regulatory writing & publishing based regulatory affairs services market, 2014 - 2025 (USD Million)
  • FIG. 38 Legal representation based regulatory affairs services market, 2014 - 2025 (USD Million)
  • FIG. 39 Other regulatory affairs services market, 2014 - 2025 (USD Million)
  • FIG. 40 Product maintenance services market, 2014 - 2025 (USD Million)
  • FIG. 41 Product design & development services market, 2014 - 2025 (USD Million)
  • FIG. 42 Product testing & validation services market, 2014 - 2025 (USD Million)
  • FIG. 43 Training & education services market, 2014 - 2025 (USD Million)
  • FIG. 44 Other services market, 2014 - 2025 (USD Million)
  • FIG. 45 Regional market place: Key takeaways
  • FIG. 46 Regional outlook, 2015 & 2025
  • FIG. 47 North America pharmaceutical/biotechnology services outsourcing market, 2014 - 2025 (USD Million)
  • FIG. 48 U.S. pharmaceutical/biotechnology services outsourcing market, 2014 - 2025 (USD Million)
  • FIG. 49 Canada pharmaceutical/biotechnology services outsourcing market, 2014 - 2025 (USD Million)
  • FIG. 50 Europe pharmaceutical/biotechnology services outsourcing market, 2014 - 2025 (USD Million)
  • FIG. 51 UK pharmaceutical/biotechnology services outsourcing market, 2014 - 2025 (USD Million)
  • FIG. 52 Germany pharmaceutical/biotechnology services outsourcing market, 2014 - 2025 (USD Million)
  • FIG. 53 Asia Pacific pharmaceutical/biotechnology services outsourcing market, 2014 - 2025 (USD Million)
  • FIG. 54 Japan pharmaceutical/biotechnology services outsourcing market, 2014 - 2025 (USD Million)
  • FIG. 55 China pharmaceutical/biotechnology services outsourcing market, 2014 - 2025 (USD Million)
  • FIG. 56 Latin America pharmaceutical/biotechnology services outsourcing market, 2014 - 2025 (USD Million)
  • FIG. 57 Brazil pharmaceutical/biotechnology services outsourcing market, 2014 - 2025 (USD Million)
  • FIG. 58 Mexico pharmaceutical/biotechnology services outsourcing market, 2014 - 2025 (USD Million)
  • FIG. 59 MEA pharmaceutical/biotechnology services outsourcing market, 2014 - 2025 (USD Million)
  • FIG. 60 South Africa pharmaceutical/biotechnology services outsourcing market, 2014 - 2025 (USD Million)
  • FIG. 61 Strategy framework
  • FIG. 62 Global presence of The Quantic Group
  • FIG. 63 SWOT Analysis
  • FIG. 64 Global presence of QuintilesIMS
  • FIG. 65 SWOT Analysis
  • FIG. 66 Global presence of Parexel International Corporation
  • FIG. 67 SWOT Analysis
  • FIG. 68 Global presence of Lachman Consultant Services, Inc.
  • FIG. 69 SWOT Analysis
  • FIG. 70 Global presence of GMP Pharmaceuticals Pty Ltd.
  • FIG. 71 SWOT Analysis
  • FIG. 72 Global presence of Management Forum
  • FIG. 73 SWOT analysis
  • FIG. 74 Global presence of Quality Context Ltd.
  • FIG. 75 SWOT analysis
  • FIG. 76 Global presence of Inspired Pharma
  • FIG. 77 SWOT analysis
  • FIG. 78 Global presence of Concept Heidelberg GmbH
  • FIG. 79 SWOT analysis
  • FIG. 80 Global presence of RSSL
  • FIG. 81 SWOT analysis
Back to Top